A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Active, not recruiting · NCT05611671 · Registry updated 2025-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 2 | 2025-12-15 | NCT05611671 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | 2 |
102 results · Page 1 of 5
Research sites
Swipe the table sideways for more columns.